HeartBeam Reorganizes to Accelerate Global Commercialization of 3D ECG Technology

HeartBeam (NASDAQ: BEAT) announced a strategic reorganization aimed at accelerating execution, expanding global market reach and improving capital efficiency as it advances commercialization of its cardiac monitoring technology. Under the new structure, Founder and President Branislav Vajdic, Ph.D., and Executive Chairman Rich Ferrari will lead focused implementation teams designed to streamline decision-making, improve accountability and reduce costs. As part of the transition, former CEO Robert Eno will move into a consulting role.

The company said its strategy centers on leveraging its patented 3D ECG platform across multiple healthcare channels while advancing development beyond arrhythmia assessment toward heart attack detection. HeartBeam also plans to expand partnerships with governments, health systems, ECG manufacturers and wearable device companies, building on its December 2025 FDA clearance for its synthesized 12-lead ECG technology for arrhythmia assessment. The company's platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence, enabling physicians to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of a medical facility.

HeartBeam's 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024 and the 12-lead ECG synthesis software in December 2025, as detailed in the full press release at https://ibn.fm/CTxXi. The company holds over 20 issued patents related to technology enablement. The reorganization is expected to improve capital efficiency and reduce costs, positioning HeartBeam for broader market penetration as it targets partnerships with ECG manufacturers and wearable device companies. The move underscores the company's commitment to transforming detection and monitoring of critical cardiac conditions through its cable-free, 3D ECG technology.

Latest news and updates relating to BEAT are available in the company's newsroom at https://ibn.fm/BEAT. Forward-looking statements involve risks and uncertainties, including those set forth under "Risk Factors" in the company's most recent Annual Report on Form 10-K and other filings with the SEC.